DV
Dividend Vision

SRPT — Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Total return is -53.6% over the past 29.2 years, 1473.9 points behind SPY at 1420.3%. Its deepest 1-year drawdown was 39.2%.

SRPT is a single-stock equity holding in Sarepta Therapeutics, a biopharmaceutical company, rather than a diversified ETF. The holding does not currently pay dividends, resulting in a distribution rate of N/A and no regular distribution frequency. This security is suited for investors seeking equity exposure to a specialized biotech firm focused on genetic medicine therapies, though it carries the concentrated risk profile typical of individual stock holdings rather than the diversification offered by traditional ETFs.

SRPT key facts

Asset type
Stock
Asset class
Equity
Inception date
06/04/1997
Distribution frequency
None
Last close
$18.10
Market cap
$1,911,849,216
Average volume
1561000.0
Beta
0.205
Payout ratio
0.0
P/E ratio
42.9189
Forward P/E
6.7204
EPS
$-1.57